Leading Pharmacologist and Pharmaceutical Scientist Joins Critical Path Institute
November 11, 2010
Thorir D. Bjornsson, MD, PhD, has joined Critical Path Institute as a member of its Board of Directors, and will also lead one of its major consortia, the Critical Path to TB Drug Regimens, Regulatory Science Consortium (CPTR).
Thank you for helping us expand participation in this important work! We rely on people with lived experience of ALS to help ensure research reflects the needs and priorities of the community. Please use the form below to nominate someone whose experiences, perspectives, and interests may make them a strong contributor to an ALS Research Working Group. No scientific or medical background is required.
